INTERNATIONAL PATENT: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, DANA-FARBER CANCER INSTITUTE, INC. FILES APPLICATION FOR "GANGLIOSIDE GM2 AS A TARGET FOR CANCER IMMUNOTHERAPY"

GENEVA, May 14 -- THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Office of the General CounselBuilding 170, 3rd Floor, Main Quad, P.O. Box 20386Stanford, California 94305-2038), DANA-FARBER CANCER INSTITUTE, INC. (450 Brookline AvenueBoston, Massachusetts 02215-5450) filed a patent application (PCT/US2024/053410) for "GANGLIOSIDE GM2 AS A TARGET FOR CANCER IMMUNOTHERAPY" on Oct 29, 2024. With publication no. WO/2025/096441, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DALTON, Guillermo (c/o The Board o...